Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 110.00
Ask: 115.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.545%)
Open: 112.50
High: 114.00
Low: 112.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 May 2021 13:55

RNS Number : 4158Y
Eco Animal Health Group PLC
12 May 2021
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Eco Animal Health Group PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Danske Bank A/S

City and country of registered office (if applicable)

DK - 1092 Copenhagen

4. Full name of shareholder(s) (if different from 3.)v

Name

 

DANSKE INVEST MANAGEMENT COMPANY (SOCIÉTE ANONYME)/DANSKE INVEST FCP LUXEMBOURG

 

DANSKE INVEST FUND MANAGEMENT LTD./DANSKE INVEST FINLAND

 

PROXY VOTES SUPPLIED BY INVESTERINGSFORENINGEN DANSKE INVEST

 

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

10-05-2021

6. Date on which issuer notified (DD/MM/YYYY):

11-05-2021

7. Total positions of person(s) subject to the notification obligation4.77109

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.925164

 

5.925164

 

67,704,416.00

Position of previous notification (if

applicable)

6.00

 

6.00

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0032036807

4,011,598.00

5.925164

SUBTOTAL 8. A

4,011,598.00

5.93

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Danske Invest FCP Luxembourg

13, rue Edward Steichen

L-2540 Luxembourg

- A mutual fund under management of

Danske Invest Management Company (Société Anonyme)

13, rue Edward Steichen

L-2540 Luxembourg

- a subsidiary 100% owned by

Danske Bank International S.A,

13, rue Edward Steichen

L-2540 Luxembourg

- a subsidiary 100% owned by Danske Bank A/S

 

2.237102%

2.237102%

Danske Invest Finland

Hiililaiturinkuja 2, P.O. Box 1553,

FIN-00180 Helsinki

Finland

- a mutual fund under management of

Danske Invest Fund Management Ltd.

Hiililaiturinkuja 2, P.O. Box 1553,

FIN-00180 Helsinki

Finland

- a subsidiary 100% owned by

Danske Bank plc

Hiililaiturinkuja 2, P.O. Box 1568

00075 Danske Bank, Finland

- a subsidiary 100% owned by Danske Bank A/S

1.607972%

1.607971%

10. In case of proxy voting, please identify:

Name of the proxy holder

DANSKE Capital, a division of Danske Bank A/S

The number and % of voting rights held

Danske Invest Europa Small cap

(1,263,857.00 indirect shs/votings rights = 1.866727%)

 

Danske Invest Europa Small cap AKK

(144,456.00 indirect shs/votings rights = 0.213363%)

The date until which the voting rights will be held

No set expiry date

11. Additional informationxvi

 

Place of completion

DK - 1092 Copenhagen K

Date of completion

11-05-2021

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLDKBBQBBKDNPD
Date   Source Headline
4th Feb 20217:02 amRNSHalf-Year Report
4th Feb 20217:00 amRNSFinal Results for Year Ended 31 March 2020
21st Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSAIVLOSIN® USA & CANADIAN MARKETING AUTHORISATIONS
7th Jan 20217:00 amRNSSwine Vaccine Brazilian Marketing Authorisation
4th Jan 20217:30 amRNSSuspension - Eco Animal Health Group Plc
23rd Dec 202011:50 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSResults for year ended 31 March 2020 delayed
24th Nov 20204:34 pmRNSNotice of Results for Year Ended 31 March 2020
22nd Oct 20205:57 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSTrading Update
15th Oct 20207:00 amRNSLicensing Deals
6th Oct 20206:19 pmRNSHolding(s) in Company
6th Oct 202012:42 pmRNSHolding(s) in Company
11th Sep 202011:08 amRNSNOTICE OF RESULTS FOR YEAR ENDED 31 MARCH 2020
23rd Jul 202010:14 amRNSHolding(s) in Company
14th Jul 20205:30 pmRNSHolding(s) in Company
29th Jun 20207:00 amRNSEUROPEAN MARKETING AUTHORISATION FOR AIVLOSIN®
18th Jun 20205:24 pmRNSHolding(s) in Company
12th Jun 202011:24 amRNSHolding(s) in Company
11th Jun 20205:01 pmRNSHolding(s) in Company
10th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSTrading Update
22nd May 20207:00 amRNSEuropean Marketing Authorisation Opinion
27th Apr 20207:00 amRNSBoard Appointment
24th Apr 20204:04 pmRNSHolding(s) in Company
9th Mar 20205:44 pmRNSHolding(s) in Company
20th Feb 20207:00 amRNSHolding(s) in Company
20th Feb 20207:00 amRNSHolding(s) in Company
3rd Feb 20207:00 amRNSBlock listing Interim Return
3rd Feb 20207:00 amRNSTotal Voting Rights
30th Jan 20207:00 amRNSMarket Authorisation in Indonesia
31st Dec 20197:00 amRNSHalf-year Report
26th Nov 20199:13 amBUSHolding(s) in Company
21st Nov 20193:25 pmBUSHolding(s) in Company
13th Nov 20199:16 amBUSHolding(s) in Company
13th Nov 20198:53 amBUSHolding(s) in Company
12th Nov 20193:16 pmBUSHolding(s) in Company
12th Nov 20193:14 pmBUSHolding(s) in Company
11th Nov 20197:00 amBUSTrading Statement
28th Oct 20192:05 pmBUSHolding(s) in Company
28th Oct 20192:03 pmBUSHolding(s) in Company
19th Sep 20193:33 pmBUSResult of AGM
11th Sep 20197:00 amBUSStatement re ECO Animal Health and The Pirbright Institute sign second poultry vaccine development licencing deal.
4th Sep 20198:17 amBUSStatement re ECO Animal Health and The Pirbright Institute sign novel poultry biopharmaceutical development licencing deal
28th Aug 20198:12 amBUSPosting of AGM Notice - Replacement
27th Aug 20191:03 pmBUSCirc re. Posting of AGM Notice
22nd Aug 20197:00 amBUSDirectorate change
19th Aug 20197:00 amBUSDirectorate change
2nd Aug 20192:24 pmBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.